Global Biosimilar Monoclonal Antibodies Industry 2016 Deep Market Research Report
- QYR555332
- 155 Pages
- April 2016
- Pharmaceuticals
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilar Monoclonal Antibodies market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.
Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the Biosimilar Monoclonal Antibodies industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview of Biosimilar Monoclonal Antibodies
1.1 Definition and Specifications of Biosimilar Monoclonal Antibodies
1.1.1 Definition of Biosimilar Monoclonal Antibodies
1.1.2 Specifications of Biosimilar Monoclonal Antibodies
1.2 Classification of Biosimilar Monoclonal Antibodies
1.3 Applications of Biosimilar Monoclonal Antibodies
1.4 Industry Chain Structure of Biosimilar Monoclonal Antibodies
1.5 Industry Overview and Major Regions Status of Biosimilar Monoclonal Antibodies
1.5.1 Industry Overview of Biosimilar Monoclonal Antibodies
1.5.2 Global Major Regions Status of Biosimilar Monoclonal Antibodies
1.6 Industry Policy Analysis of Biosimilar Monoclonal Antibodies
1.7 Industry News Analysis of Biosimilar Monoclonal Antibodies
2 Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies
2.1 Raw Material Suppliers and Price Analysis of Biosimilar Monoclonal Antibodies
2.2 Equipment Suppliers and Price Analysis of Biosimilar Monoclonal Antibodies
2.3 Labor Cost Analysis of Biosimilar Monoclonal Antibodies
2.4 Other Costs Analysis of Biosimilar Monoclonal Antibodies
2.5 Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies
2.6 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
3 Technical Data and Manufacturing Plants Analysis of Biosimilar Monoclonal Antibodies
3.1 Capacity and Commercial Production Date of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
4 Capacity, Production and Revenue Analysis of Biosimilar Monoclonal Antibodies by Regions, Types and Manufacturers
4.1 Global Capacity, Production and Revenue of Biosimilar Monoclonal Antibodies by Regions 2011-2016
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
4.3 Global Capacity, Production and Revenue of Biosimilar Monoclonal Antibodies by Types 2011-2016
4.4 Global Capacity, Production and Revenue of Biosimilar Monoclonal Antibodies by Manufacturers 2011-2016
5 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Monoclonal Antibodies by Regions, Types and Manufacturers
5.1 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Monoclonal Antibodies by Regions 2011-2016
5.2 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Monoclonal Antibodies by Types 2011-2016
5.3 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Monoclonal Antibodies by Manufacturers 2011-2016
6 Consumption Volume, Consumption Value and Sale Price Analysis of Biosimilar Monoclonal Antibodies by Regions, Types and Applications
6.1 Global Consumption Volume and Consumption Value of Biosimilar Monoclonal Antibodies by Regions 2011-2016
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
6.3 Global Consumption Volume and Consumption Value of Biosimilar Monoclonal Antibodies by Types 2011-2016
6.4 Global Consumption Volume and Consumption Value of Biosimilar Monoclonal Antibodies by Applications 2011-2016
6.5 Sale Price of Biosimilar Monoclonal Antibodies by Regions 2011-2016
6.6 Sale Price of Biosimilar Monoclonal Antibodies by Types 2011-2016
6.7 Sale Price of Biosimilar Monoclonal Antibodies by Applications 2011-2016
6.8 Market Share Analysis of Biosimilar Monoclonal Antibodies by Different Sale Price Levels
7 Supply, Import, Export and Consumption Analysis of Biosimilar Monoclonal Antibodies
7.1 Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2011-2016
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016
7.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016
7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016
7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016
8 Major Manufacturers Analysis of Biosimilar Monoclonal Antibodies
8.1 BioXpress
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Type I
8.1.2.2 Type II
8.1.2.3 Type III
8.1.3 Capacity, Production, Price, Cost, Gross and Revenue
8.1.4 Contact Information
8.2 Harvest Moon
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Type I
8.2.2.2 Type II
8.2.2.3 Type III
8.2.3 Capacity, Production, Price, Cost, Gross and Revenue
8.2.4 Contact Information
8.3 Celltrion
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Type I
8.3.2.2 Type II
8.3.2.3 Type III
8.3.3 Capacity, Production, Price, Cost, Gross and Revenue
8.3.4 Contact Information
8.4 Harvest Moon
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Type I
8.4.2.2 Type II
8.4.2.3 Type III
8.4.3 Capacity, Production, Price, Cost, Gross and Revenue
8.4.4 Contact Information
8.5 Gene Techno Science
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Type I
8.5.2.2 Type II
8.5.2.3 Type III
8.5.3 Capacity, Production, Price, Cost, Gross and Revenue
8.5.4 Contact Information
8.6 Mabion
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Type I
8.6.2.2 Type II
8.6.2.3 Type III
8.6.3 Capacity, Production, Price, Cost, Gross and Revenue
8.6.4 Contact Information
8.7 India's Biocon
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Type I
8.7.2.2 Type II
8.7.2.3 Type III
8.7.3 Capacity, Production, Price, Cost, Gross and Revenue
8.7.4 Contact Information
8.8 Pfizer
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Type I
8.8.2.2 Type II
8.8.2.3 Type III
8.8.3 Capacity, Production, Price, Cost, Gross and Revenue
8.8.4 Contact Information
8.9 BIOCAD
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Type I
8.9.2.2 Type II
8.9.2.3 Type III
8.9.3 Capacity, Production, Price, Cost, Gross and Revenue
8.9.4 Contact Information
9 Marketing Trader or Distributor Analysis of Biosimilar Monoclonal Antibodies
9.1 Marketing Channels Status of Biosimilar Monoclonal Antibodies
9.2 Traders or Distributors with Contact Information of Biosimilar Monoclonal Antibodies by Regions
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilar Monoclonal Antibodies
9.4 Regional Import, Export and Trade Analysis of Biosimilar Monoclonal Antibodies
10 Industry Chain Analysis of Biosimilar Monoclonal Antibodies
10.1 Upstream Major Raw Materials Suppliers Analysis of Biosimilar Monoclonal Antibodies
10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Biosimilar Monoclonal Antibodies
10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Biosimilar Monoclonal Antibodies by Regions
10.2 Upstream Major Equipment Suppliers Analysis of Biosimilar Monoclonal Antibodies
10.2.1 Major Equipment Suppliers with Contact Information Analysis of Biosimilar Monoclonal Antibodies
10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Biosimilar Monoclonal Antibodies by Regions
10.3 Downstream Major Consumers Analysis of Biosimilar Monoclonal Antibodies
10.3.1 Major Consumers with Contact Information Analysis of Biosimilar Monoclonal Antibodies
10.3.2 Major Consumers with Consumption Volume Analysis of Biosimilar Monoclonal Antibodies by Regions
10.4 Supply Chain Relationship Analysis of Biosimilar Monoclonal Antibodies
11 Development Trend of Analysis of Biosimilar Monoclonal Antibodies
11.1 Capacity, Production and Revenue Forecast of Biosimilar Monoclonal Antibodies by Regions and Types
11.1.1 Global Capacity, Production and Revenue of Biosimilar Monoclonal Antibodies by Regions 2016-2021
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
11.1.3 Global Capacity, Production and Revenue of Biosimilar Monoclonal Antibodies by Types 2016-2021
11.2 Consumption Volume and Consumption Value Forecast of Biosimilar Monoclonal Antibodies by Regions, Types and Applications
11.2.1 Global Consumption Volume and Consumption Value of Biosimilar Monoclonal Antibodies by Regions 2016-2021
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
11.2.3 Global Consumption Volume and Consumption Value of Biosimilar Monoclonal Antibodies by Types 2016-2021
11.2.4 Global Consumption Volume and Consumption Value of Biosimilar Monoclonal Antibodies by Applications 2016-2021
11.3 Supply, Import, Export and Consumption Forecast of Biosimilar Monoclonal Antibodies
11.3.1 Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2016-2021
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021
11.3.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021
11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021
11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021
12 New Project Investment Feasibility Analysis of Biosimilar Monoclonal Antibodies
12.1 New Project SWOT Analysis of Biosimilar Monoclonal Antibodies
12.2 New Project Investment Feasibility Analysis of Biosimilar Monoclonal Antibodies
13 Conclusion of the Global Biosimilar Monoclonal Antibodies Industry 2016 Market Research Report
Figure Picture of Biosimilar Monoclonal Antibodies
Table Product Specifications of Biosimilar Monoclonal Antibodies
Table Classification of Biosimilar Monoclonal Antibodies
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Types in 2015
Table Applications of Biosimilar Monoclonal Antibodies
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Applications in 2015
Figure Industry Chain Structure of Biosimilar Monoclonal Antibodies
Table Global Biosimilar Monoclonal Antibodies Major Manufacturers
Table Global Major Regions Biosimilar Monoclonal Antibodies Development Status
Table Industry Policy of Biosimilar Monoclonal Antibodies
Table Industry News List of Biosimilar Monoclonal Antibodies
Table Raw Material Suppliers and Price Analysis
Table Equipment Suppliers and Price Analysis
Table Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies in 2015
Figure Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
Table Capacity (K mg) and Commercial Production Date of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Manufacturing Plants Distribution of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table R&D Status and Technology Source of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Raw Materials Sources Analysis of Global Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Global Capacity (K mg) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies by Regions in 2011
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies by Regions in 2015
Table Global Production (K mg) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Regions in 2011
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Regions in 2015
Table Global Revenue (M USD) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies by Regions in 2011
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies by Regions in 2015
Figure Global Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Global Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Global Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure United States Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure United States Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure United States Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Europe Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Europe Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Europe Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure China Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure China Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure China Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Japan Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Japan Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Japan Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Table Global Capacity (K mg) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies by Types in 2011
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies by Types in 2015
Table Global Production (K mg) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Types in 2011
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Types in 2015
Table Global Revenue (M USD) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies by Types in 2011
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies by Types in 2015
Table Global and Major Manufacturers Capacity (K mg) of Biosimilar Monoclonal Antibodies 2011-2016
Table Global Capacity Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers 2011-2016
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers in 2011
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Global and Major Manufacturers Production (K mg) of Biosimilar Monoclonal Antibodies 2011-2016
Table Global Production Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers 2011-2016
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers in 2011
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Global and Major Manufacturers Revenue (M USD) of Biosimilar Monoclonal Antibodies 2011-2016
Table Global Revenue Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers 2011-2016
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers in 2011
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies Major Manufacturers in 2015
Table Price (USD/mg) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Price (USD/mg) of Biosimilar Monoclonal Antibodies by Regions in 2015
Table Cost (USD/mg) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Cost (USD/mg) of Biosimilar Monoclonal Antibodies by Regions in 2015
Table Gross (USD/mg) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Gross (USD/mg) of Biosimilar Monoclonal Antibodies by Regions in 2015
Table Gross Margin of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Gross Margin of Biosimilar Monoclonal Antibodies by Regions in 2015
Table Price (USD/mg) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Price (USD/mg) of Biosimilar Monoclonal Antibodies by Types in 2015
Table Cost (USD/mg) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Cost (USD/mg) of Biosimilar Monoclonal Antibodies by Types in 2015
Table Gross (USD/mg) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Gross (USD/mg) of Biosimilar Monoclonal Antibodies by Types in 2015
Table Gross Margin of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Gross Margin of Biosimilar Monoclonal Antibodies by Types in 2015
Table Price (USD/mg) of Biosimilar Monoclonal Antibodies by Manufacturers 2011-2016
Figure Price (USD/mg) of Biosimilar Monoclonal Antibodies by Manufacturers in 2015
Table Cost (USD/mg) of Biosimilar Monoclonal Antibodies by Manufacturers 2011-2016
Figure Cost (USD/mg) of Biosimilar Monoclonal Antibodies by Manufacturers in 2015
Table Gross (USD/mg) of Biosimilar Monoclonal Antibodies by Manufacturers 2011-2016
Figure Gross (USD/mg) of Biosimilar Monoclonal Antibodies by Manufacturers in 2015
Table Gross Margin of Biosimilar Monoclonal Antibodies by Manufacturers 2011-2016
Figure Gross Margin of Biosimilar Monoclonal Antibodies by Manufacturers in 2015
Table Global Consumption Volume (K mg) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Regions in 2011
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Regions in 2015
Table Global Consumption Value (M USD) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Regions in 2011
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Regions in 2015
Figure Global Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Global Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure United States Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure United States Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Europe Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Europe Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure China Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure China Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Japan Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Figure Japan Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2011-2016
Table Global Consumption Volume (K mg) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Types in 2011
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Types in 2015
Table Global Consumption Value (M USD) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Types in 2011
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Types in 2015
Table Global Consumption Volume (K mg) of Biosimilar Monoclonal Antibodies by Applications 2011-2016
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Applications in 2011
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Applications in 2015
Table Global Consumption Value (M USD) of Biosimilar Monoclonal Antibodies by Applications 2011-2016
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Applications in 2011
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Applications in 2015
Table Sale Price (USD/mg) of Biosimilar Monoclonal Antibodies by Regions 2011-2016
Figure Sale Price (USD/mg) of Biosimilar Monoclonal Antibodies by Regions in 2015
Table Sale Price (USD/mg) of Biosimilar Monoclonal Antibodies by Types 2011-2016
Figure Sale Price (USD/mg) of Biosimilar Monoclonal Antibodies by Types in 2015
Table Sale Price (USD/mg) of Biosimilar Monoclonal Antibodies by Applications 2011-2016
Figure Sale Price (USD/mg) of Biosimilar Monoclonal Antibodies by Applications in 2015
Table Market Share of Biosimilar Monoclonal Antibodies by Different Sale Price Levels
Table Global Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table United States Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table Europe Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table China Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table Japan Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table Global Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2011-2016
Table United States Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2011-2016
Table United States Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table Europe Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2011-2016
Table Europe Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table China Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2011-2016
Table China Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table Japan Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2011-2016
Table Japan Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2011-2016 (K mg)
Table BioXpress Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of BioXpress
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of BioXpress 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of BioXpress 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of BioXpress 2011-2016
Table Harvest Moon Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of Harvest Moon
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of Harvest Moon 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of Harvest Moon 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of Harvest Moon 2011-2016
Table Celltrion Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of Celltrion
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of Celltrion 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of Celltrion 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of Celltrion 2011-2016
Table Harvest Moon Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of Harvest Moon
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of Harvest Moon 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of Harvest Moon 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of Harvest Moon 2011-2016
Table Gene Techno Science Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of Gene Techno Science
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of Gene Techno Science 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of Gene Techno Science 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of Gene Techno Science 2011-2016
Table Mabion Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of Mabion
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of Mabion 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of Mabion 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of Mabion 2011-2016
Table India's Biocon Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of India's Biocon
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of India's Biocon 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of India's Biocon 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of India's Biocon 2011-2016
Table Pfizer Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of Pfizer
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of Pfizer 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of Pfizer 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of Pfizer 2011-2016
Table BIOCAD Information List
Figure Biosimilar Monoclonal Antibodies Picture and Specifications of BIOCAD
Table Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Gross (USD/mg), Revenue (M USD) and Gross Margin of BIOCAD 2011-2016
Figure Biosimilar Monoclonal Antibodies Capacity (K mg), Production (K mg) and Growth Rate of BIOCAD 2011-2016
Figure Biosimilar Monoclonal Antibodies Production (K mg) and Global Market Share of BIOCAD 2011-2016
Figure Marketing Channels of Biosimilar Monoclonal Antibodies
Table Traders or Distributors with Contact Information of Biosimilar Monoclonal Antibodies by Regions
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilar Monoclonal Antibodies (USD/mg)
Table Regional Import, Export, and Trade of Biosimilar Monoclonal Antibodies (K mg)
Table Flow of International Trade in 2015
Table Major Raw Materials Suppliers with Contact Information of Biosimilar Monoclonal Antibodies
Table Major Raw Materials Suppliers with Supply Volume of Biosimilar Monoclonal Antibodies by Regions
Table Major Equipment Suppliers with Contact Information of Biosimilar Monoclonal Antibodies
Table Major Equipment Suppliers with Product Pictures of Biosimilar Monoclonal Antibodies by Regions
Table Major Consumers with Contact Information of Biosimilar Monoclonal Antibodies
Table Major Consumers with Consumption Volume of Biosimilar Monoclonal Antibodies by Regions
Figure Supply Chain Relationship Analysis of Biosimilar Monoclonal Antibodies
Table Global Capacity (K mg) of Biosimilar Monoclonal Antibodies by Regions 2016-2021
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies by Regions in 2016
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies by Regions in 2021
Table Global Production (K mg) of Biosimilar Monoclonal Antibodies by Regions 2016-2021
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Regions in 2016
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Regions in 2021
Table Global Revenue (M USD) of Biosimilar Monoclonal Antibodies by Regions 2016-2021
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies by Regions in 2016
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies by Regions in 2021
Figure Global Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Global Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Global Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure United States Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure United States Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure United States Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Europe Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Europe Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Europe Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure China Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure China Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure China Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Japan Capacity (K mg), Production (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Japan Capacity Utilization Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Japan Revenue (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Table Global Capacity (K mg) of Biosimilar Monoclonal Antibodies by Types 2016-2021
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies by Types in 2016
Figure Global Capacity Market Share of Biosimilar Monoclonal Antibodies by Types in 2021
Table Global Production (K mg) of Biosimilar Monoclonal Antibodies by Types 2016-2021
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Types in 2016
Figure Global Production Market Share of Biosimilar Monoclonal Antibodies by Types in 2021
Table Global Revenue (M USD) of Biosimilar Monoclonal Antibodies by Types 2016-2021
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies by Types in 2016
Figure Global Revenue Market Share of Biosimilar Monoclonal Antibodies by Types in 2021
Table Global Consumption Volume (K mg) of Biosimilar Monoclonal Antibodies by Regions 2016-2021
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Regions in 2016
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Regions in 2021
Table Global Consumption Value (M USD) of Biosimilar Monoclonal Antibodies by Regions 2016-2021
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Regions in 2016
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Regions in 2021
Figure Global Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Global Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure United States Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure United States Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Europe Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Europe Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure China Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure China Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Japan Consumption Volume (K mg) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Figure Japan Consumption Value (M USD) and Growth Rate of Biosimilar Monoclonal Antibodies 2016-2021
Table Global Consumption Volume (K mg) of Biosimilar Monoclonal Antibodies by Types 2016-2021
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Types in 2016
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Types in 2021
Table Global Consumption Value (M USD) of Biosimilar Monoclonal Antibodies by Types 2016-2021
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Types in 2016
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Types in 2021
Table Global Consumption Volume (K mg) of Biosimilar Monoclonal Antibodies by Applications 2016-2021
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Applications in 2016
Figure Global Consumption Volume Market Share of Biosimilar Monoclonal Antibodies by Applications in 2021
Table Global Consumption Value (M USD) of Biosimilar Monoclonal Antibodies by Applications 2016-2021
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Applications in 2016
Figure Global Consumption Value Market Share of Biosimilar Monoclonal Antibodies by Applications in 2021
Table Global Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table United States Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table Europe Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table China Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table Japan Supply, Consumption and Gap of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table Global Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2016-2021
Table United States Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2016-2021
Table United States Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table Europe Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2016-2021
Table Europe Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table China Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2016-2021
Table China Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table Japan Capacity (K mg), Production (K mg), Price (USD/mg), Cost (USD/mg), Revenue (M USD) and Gross Margin of Biosimilar Monoclonal Antibodies 2016-2021
Table Japan Supply, Import, Export and Consumption of Biosimilar Monoclonal Antibodies 2016-2021 (K mg)
Table New Project SWOT Analysis of Biosimilar Monoclonal Antibodies
Table New Project Investment Feasibility Analysis of Biosimilar Monoclonal Antibodies
Table Part of Interviewees Record List
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
